期刊文献+

叉头样转录因子3的表达及其甲基化状态在肝细胞性肝癌患者中的研究 被引量:5

Expression and methylation status of Foxp3 in human hepatocellular carcinoma
原文传递
导出
摘要 目的研究叉头样转录因子3(Foxp3)的表达及启动子区甲基化水平在肝细胞性肝癌(HCC)与正常肝组织中的差异及其在HCC发病中的作用。方法使用荧光定量PCR检测39例HCC及13例正常肝组织中Foxp3mRNA水平,通过焦磷酸测序的方法检测其启动子区甲基化水平;组间比较采用秩和检验,相关性分析采用Spearman秩相关,P<0.05为差异有统计学意义。结果Foxp3mRNA在肝癌组织中相对表达量为8.54±18.30,高于正常肝组织的4.88±14.72,两组比较,Z=-2.770,P=0.0056,差异有统计学意义。Foxp3启动子区A位点的甲基化水平在正常肝组织为90.60±3.50,高于肝癌组织的80.96±20.86,两组比较,Z=2.118,P=0.0339,差异有统计学意义;而正常肝组织和肝癌组织Foxp3启动子区其余B、C、D、E4个位点和整体甲基化水平比较,P值均>0.05,差异均无统计学意义。Foxp3 mRNA水平与A位点的甲基化水平相关性分析r=-0.344,P=0.046,呈负相关;而其余4个位点与FoxD3 mRNA水平均无相关性∽值均〉0.05)。结论Foxp3高表达与Foxp3启动子区A位点低甲基化可能参与肝癌的发生和发展。 Objective To gain insights into the role of forkhead box protein 3 (Foxp3) in the pathogenesis of hepatocellular carcinoma (HCC) by performing a comparative analysis of Foxp3 mRNA expression and promoter methylation status in HCC and normal liver tissues. Methods Thirty-nine HCC and 13 normal liver tissue specimens were evaluated by real-time quantitative PCR and pyrosequencing to measure the expression of Foxp3 mRNA and determine the methylation status of its promoter, respectively. Statistical analyses of the data were conducted by rank-sum test and Spearman's rank correlation coefficient test. Results The HCC specimens showed significantly higher mRNA expression of Foxp3 (vs. normal liver tissues, Z = -2.770, P = 0.0056). Moreover, the HCC specimens showed significant hypomethylation of the Foxp3 promoter site A (vs. normal liver tissues, Z = 2.118, P = 0.0339), and the Foxp3 rnRNA level was negatively correlated with the methylation of site A (rs = -0.344, P = 0.046). None of the other four sites in the Foxp3 promoter showed a significant difference in methylation, and the overall methylation was not significantly different between the HCC and normal liver tissues. Conclusion Overexpression and low methylation of Foxp3 may be involved in the oncogenic and nrogression processes of HCC.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2014年第8期616-619,共4页 Chinese Journal of Hepatology
基金 陕西省2012科技计划项目(NO.2012K13-01-14)
关键词 肝细胞 DNA甲基化 叉头样转录因子3 Carcinoma, hepatocellular DNAmethylation Forkhead box protein 3
作者简介 党珊女,34岁,医学硕士。E-mail:shah.dang@gmail.com.
  • 相关文献

参考文献12

  • 1Hinz S, Pagerols-Raluy L, Oberg HH, et al. Foxp3 expression in pancreatic carcinoma ceils as a novel mechanism of immune evasion in cancer[J]. Cancer Res, 2007, 67: 8344-8350.
  • 2Ebert LM, Tan BS, Browning J, et al. The regulatory T cell- associated transcription factor FoxP3 is expressed by tumor cells[J]. Cancer Res, 2008, 68: 3001-3009.
  • 3Kitagawa Y, Ohkura N, Sakaguchi S. Molecular determinants of regulatory T cell development: the essential roles of epigenetic changes[J]. Front Immunol, 2013, 4: 106.
  • 4Lal G, Bromberg JS. Epigenetic mechanisms of regulation of Foxp3 expression[J]. Blood, 2009, 114: 3727-3735.
  • 5Nagar M, Vernitsky H, Cohen Y, et al. Epigenetic inheritance of DNA methylation limits activation-induced expression of FOXP3 in conventional human CD25-CD4+ T cells[J]. Int Imrnunol, 2008, 20: 1041-1055.
  • 6Lal G, Zhang N, van der Touw W, et al. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation[J], jr Irnmunol, 2009, 182: 259-273.
  • 7Katoh H, Zheng P, Liu Y. FOXP3: genetic and epigenetic implications for autoimmunity[J]. J Autoimmun, 2013, 41: 72-78.
  • 8Gupta S, Joshi K, Wig JD, et al. Intratumoral FOXP3 expression in infiltrating breast carcinoma : Its association with clinicopathological parameters and angiogenesis[J]. Acta Oncol, 2007, 46: 792-797.
  • 9黄勇,王凤梅,王涛,王毅军,朱争艳,高英堂,杜智.癌组织浸润的FoxP3^+调节性T淋巴细胞与CD34表达及肝癌患者的预后相关[J].中华肝脏病杂志,2012,20(1):25-29. 被引量:6
  • 10I Kobayashi N, Hiraoka N, Yamagami W, et al. FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis[J]. Clin Cancer Res, 2007, 13:902-911.

二级参考文献18

  • 1张恒辉,费然,梅铭惠,廖维甲,王雪艳,丛旭,覃理灵,季颖,王松霞,魏来,陈红松.原发性肝细胞癌患者CD4^+CD25^+调节性T淋巴细胞的频率、表型及功能[J].中华肝脏病杂志,2007,15(4):266-272. 被引量:4
  • 2Zhang Henghui,MEI Minghui,FEI Ran,et al.Regulatory T cell depletion enhances tumor specific CD8 T-cell responses elicited by tumor antigen vaccine NY-ESO-1 b in hepatocellular carcinoma patients[J],Cytotherapy,2009,in press.
  • 3Dannull J,Su Z,Rizzieri D.Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells[J].J Clin Invest,2005,115(12):3623-3633.
  • 4Sutmuller RP,van Duivenvoorde LM,van Elsas A,et al.Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25 (+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses[J].J Exp Med,2001,194 (6):823 -832.
  • 5Vaclavkova P,Cao Y,Wu LK,et al.A comparison of an antiCD25 immunotoxin,Ontak and anti-CD25 microbeads for their ability to deplete alloreactive T cells in vitro[J].Bone Marrow Transplant,2006,37(6):559-567.
  • 6Attia P,Maker AV,Haworth LR,et al.Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox,DAB389IL-2,ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma[J].J Immunother,2005,28(6):582 -592.
  • 7Fontenot JD,Gavin MA,Rudensky AY,et al.Foxp3 programs the development and function of CD4^+ CD25^+ regulatory T cells[J].Nat Immunol,2003,4(4):330-336.
  • 8Fontenot JD,Rasmussen P,Williams LM,et al.Regulatory T cell lineage specification by the forkhead transcription factor foxp3[J].Immunity,2005,22(3):329-341.
  • 9Sobin LH,Wittekind CH.TNM classification of malignant tumours[M].6th ed.New York,USA:Wiley,2002:81 -83.
  • 10Morgan ME,van Bilsen JH,Bakker AM,et al.Expression of FOXP3 mRNA is not confined to CD4 (+) CD25 (+) T regulatory cells in humans[J].Hum Immunol,2005,66 (1):13-20.

共引文献11

同被引文献29

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部